The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
A Trial of a 9-Valent Pneumococcal Conjugate Vaccine in Children with and Those without HIV Infection
Open accessAbstract
BACKGROUND: Acute respiratory tract infections caused by Streptococcus pneumoniae are a leading cause of morbidity and mortality in young children. We evaluated the efficacy of a 9-valent pneumococcal conjugate vaccine in a randomized, double-blind study in Soweto, South Africa. METHODS: At 6, 10, and 14 weeks of age, 19,922 children received the 9-valent pneumococcal polysaccharide vaccine conjugated to a noncatalytic cross-reacting mutant of diphtheria toxin (CRM197), and 19,914 received placebo. All children received Haemophilus influenzae type b conjugate vaccine. Efficacy and safety were analyzed according to the intention-to-treat principle. RESULTS: Among children without human immunodeficiency virus (HIV) infection, the vaccine reduced the incidence of a first episode of invasive pneumococcal disease due to serotypes included in the vaccine by 83 percent (95 percent confidence interval, 39 to 97; 17 cases among controls and 3 among vaccine recipients). Among HIV-infected children, the efficacy was 65 percent (95 percent confidence interval, 24 to 86; 26 and 9 cases, respectively). Among children without HIV infection, the vaccine reduced the incidence of first episodes of radiologically confirmed alveolar consolidation by 20 percent (95 percent confidence interval, 2 to 35; 212 cases in the control group and 169 in the vaccinated group) in the intention-to-treat analysis and by 25 percent (95 percent confidence interval, 4 to 41; 158 and 119 cases, respectively) in the per-protocol analysis (i.e., among fully vaccinated children). The incidence of invasive pneumococcal disease caused by penicillin-resistant strains was reduced by 67 percent (95 percent confidence interval, 19 to 88; 21 cases in the control group and 7 in the vaccinated group), and that caused by strains resistant to trimethoprim-sulfamethoxazole was reduced by 56 percent (95 percent confidence interval, 16 to 78; 32 and 14 cases, respectively). CONCLUSIONS: Vaccination with a 9-valent pneumococcal conjugate vaccine reduced the incidence of radiologically confirmed pneumonia. The vaccine also reduced the incidence of vaccine-serotype and antibiotic-resistant invasive pneumococcal disease among children with and those without HIV infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Methods in Cancer Research
Breslow, N. E. (1980) · Cited by 7,332
Surveillance for Foodborne Disease Outbreaks—United States, 2006
(2010) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2009.11.004 · Cited by 2,361
Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children
BLACK, S., SHINEFIELD, H., FIREMAN, B., LEWIS, E., RAY, P., HANSEN, J. R., ELVIN, L., ENSOR, K. M., HACKELL, J., SIBER, G., et al. (2000) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200003000-00003 · Cited by 2,293
Self-citationWhitney, C. G., Farley, M. M., Hadler, J., Harrison, L. H., Bennett, N. M., Lynfield, R., Reingold, A., Cieslak, P. R., Pilishvili, T., Jackson, D., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022823 · Cited by 2,228
The design and analysis of cohort studies
Breslow, N. E., & Day, N. E. (1987) · International Agency for Research on Cancer eBooks · Cited by 1,312
Estimates of world-wide distribution of child deaths from acute respiratory infections
Williams, B. G., Gouws, E., Boschi-Pinto, C., Bryce, J., & Dye, C. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(01)00170-0 · Cited by 947
Increasing Prevalence of Multidrug-Resistant Streptococcus pneumoniae in the United States
Whitney, C. G., Farley, M. M., Hadler, J., Harrison, L. H., Lexau, C., Reingold, A., Lefkowitz, L., Cieslak, P. R., Cetron, M., Zell, E. R., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012283432603 · Cited by 888
Hausdorff, W. P., Bryant, J., Paradiso, P. R., & Siber, G. R. (2000) · Clinical Infectious Diseases · doi:10.1086/313608 · Cited by 866
Pneumococcal resistance to antibiotics
Klugman, K. P. (1990) · Clinical Microbiology Reviews · doi:10.1128/cmr.3.2.171 · Cited by 799
Self-citationCigarette Smoking and Invasive Pneumococcal Disease
Nuorti, J. P., Butler, J. C., Farley, M. M., Harrison, L. H., McGeer, A., Kolczak, M. S., & Breiman, R. F. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003093421002 · Cited by 798
Cited by
O'Brien, K. L., Wolfson, L. J., Watt, J. P., Henkle, E., Deloria-Knoll, M., McCall, N., Lee, E., Mulholland, K., Levine, O. S., & Cherian, T. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61204-6 · Cited by 2,398
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
Rubin, L. G., Levin, M. J., Ljungman, P., Davies, E. G., Avery, R., Tomblyn, M., Bousvaros, A., Dhanireddy, S., Sung, L., Keyserling, H., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit684 · Cited by 1,613
Access to effective antimicrobials: a worldwide challenge
Laxminarayan, R., Matsoso, P., Pant, S., Brower, C., Røttingen, J.-A., Klugman, K., & Davies, S. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00474-2 · Cited by 1,465
Self-citationEpidemiology and etiology of childhood pneumonia
Rudan, I. (2008) · Bulletin of the World Health Organization · doi:10.2471/blt.07.048769 · Cited by 1,422
Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults
Bonten, M. J. M., Huijts, S. M., Bolkenbaas, M., Webber, C., Patterson, S., Gault, S., van Werkhoven, C. H., van Deursen, A. M. M., Sanders, E. A. M., Verheij, T. J. M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1408544 · Cited by 1,248
The ‘hygiene hypothesis’ for autoimmune and allergic diseases: an update
Okada, H., Kuhn, C., Feillet, H., & Bach, J.-F. (2010) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2010.04139.x · Cited by 1,164
Wahl, B., O'Brien, K. L., Greenbaum, A., Majumder, A., Liu, L., Chu, Y., Lukšić, I., Nair, H., McAllister, D. A., Campbell, H., et al. (2018) · The Lancet Global Health · doi:10.1016/s2214-109x(18)30247-x · Cited by 1,118
Serotype replacement in disease after pneumococcal vaccination
Weinberger, D. M., Malley, R., & Lipsitch, M. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62225-8 · Cited by 1,020
Respiratory risks from household air pollution in low and middle income countries
Gordon, S. B., Bruce, N. G., Grigg, J., Hibberd, P. L., Kurmi, O. P., Lam, K.-B. H., Mortimer, K., Asante, K. P., Balakrishnan, K., Balmes, J., et al. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70168-7 · Cited by 953
Cutts, F., Zaman, S., Enwere, G., Jaffar, S., Levine, O., Okoko, J., Oluwalana, C., Vaughan, A., Obaro, S., Leach, A., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)71876-6 · Cited by 900
Self-citationKyaw, M. H., Lynfield, R., Schaffner, W., Craig, A. S., Hadler, J., Reingold, A., Thomas, A. R., Harrison, L. H., Bennett, N. M., Farley, M. M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa051642 · Cited by 881
O'Brien, K. L., Baggett, H. C., Brooks, W. A., Feikin, D. R., Hammitt, L. L., Higdon, M. M., Howie, S. R. C., Deloria Knoll, M., Kotloff, K. L., Levine, O. S., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30721-4 · Cited by 879
Self-citationBacteremia among Children Admitted to a Rural Hospital in Kenya
Berkley, J. A., Lowe, B. S., Mwangi, I., Williams, T., Bauni, E., Mwarumba, S., Ngetsa, C., Slack, M. P. E., Njenga, S., Hart, C. A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa040275 · Cited by 851
Grijalva, C. G., Nuorti, J. P., Arbogast, P. G., Martin, S. W., Edwards, K. M., & Griffin, M. R. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60564-9 · Cited by 667
The fundamental link between pneumococcal carriage and disease
Simell, B., Auranen, K., Käyhty, H., Goldblatt, D., Dagan, R., O’Brien, K. L., & for the Pneumococcal Carriage Group (PneumoCarr) (2012) · Expert Review of Vaccines · doi:10.1586/erv.12.53 · Cited by 633
Whitney, C. G., Pilishvili, T., Farley, M. M., Schaffner, W., Craig, A. S., Lynfield, R., Nyquist, A.-C., Gershman, K. A., Vazquez, M., Bennett, N. M., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69637-2 · Cited by 623
Epidemiological differences among pneumococcal serotypes
Hausdorff, W. P., Feikin, D. R., & Klugman, K. P. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)01280-6 · Cited by 606
Self-citationA role for Streptococcus pneumoniae in virus-associated pneumonia
Madhi, S. A., Klugman, K. P., & The Vaccine Trialist Group (2004) · Nature Medicine · doi:10.1038/nm1077 · Cited by 565
Self-citationAndrews, N. J., Waight, P. A., Burbidge, P., Pearce, E., Roalfe, L., Zancolli, M., Slack, M., Ladhani, S. N., Miller, E., & Goldblatt, D. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70822-9 · Cited by 545
Effects of Vaccination on Invasive Pneumococcal Disease in South Africa
von Gottberg, A., de Gouveia, L., Tempia, S., Quan, V., Meiring, S., von Mollendorf, C., Madhi, S. A., Zell, E. R., Verani, J. R., O’Brien, K. L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1401914 · Cited by 373
Self-citationEstimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies
Siber, G. R., Chang, I., Baker, S., Fernsten, P., O’Brien, K. L., Santosham, M., Klugman, K. P., Madhi, S. A., Paradiso, P., & Kohberger, R. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.01.119 · Cited by 366
Self-citationPrevention of hospital-associated pneumonia and ventilator-associated pneumonia
Kollef, M. H. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000128569.09113.fb · Cited by 366
A Trial of a 7-Valent Pneumococcal Conjugate Vaccine in HIV-Infected Adults
French, N., Gordon, S. B., Mwalukomo, T., White, S. A., Mwafulirwa, G., Longwe, H., Mwaiponya, M., Zijlstra, E. E., Molyneux, M. E., & Gilks, C. F. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0903029 · Cited by 352
Otitis media and its consequences: beyond the earache
Vergison, A., Dagan, R., Arguedas, A., Bonhoeffer, J., Cohen, R., DHooge, I., Hoberman, A., Liese, J., Marchisio, P., Palmu, A. A., et al. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70012-8 · Cited by 341
Munoz-Almagro, C., Jordan, I., Gene, A., Latorre, C., Garcia-Garcia, J. J., & Pallares, R. (2008) · Clinical Infectious Diseases · doi:10.1086/524660 · Cited by 333
The Influence of Chronic Illnesses on the Incidence of Invasive Pneumococcal Disease in Adults
Kyaw, M. H., Rose, Jr., Fry, A. M., Singleton, J. A., Moore, Z., Zell, E. R., Whitney, C. G., & Active Bacterial Core Surveillance Program of the Emerging Infections Program Network (2005) · The Journal of Infectious Diseases · doi:10.1086/431521 · Cited by 328
Effect of vaccines on bacterial meningitis worldwide
McIntyre, P. B., O'Brien, K. L., Greenwood, B., & van de Beek, D. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61187-8 · Cited by 326
Mejias, A., Dimo, B., Suarez, N. M., Garcia, C., Suarez-Arrabal, M. C., Jartti, T., Blankenship, D., Jordan-Villegas, A., Ardura, M. I., Xu, Z., et al. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001549 · Cited by 313
Kim, L., McGee, L., Tomczyk, S., & Beall, B. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-15 · Cited by 285
Lynch, J. P., & Zhanel, G. G. (2010) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e3283385653 · Cited by 271
Hansen, J., Black, S., Shinefield, H., Cherian, T., Benson, J., Fireman, B., Lewis, E., Ray, P., & Lee, J. (2006) · Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000232706.35674.2f · Cited by 268
Vesikari, T., Wysocki, J., Chevallier, B., Karvonen, A., Czajka, H., Arsène, J.-P., Lommel, P., Dieussaert, I., & Schuerman, L. (2009) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e318199f8ef · Cited by 268
Protein carriers of conjugate vaccines: Characteristics, development and clinical trials
Pichichero, M. E. (2013) · Human vaccines & immunotherapeutics · doi:10.4161/hv.26109 · Cited by 261
O’Brien, K. L., Millar, E. V., Zell, E. R., Bronsdon, M., Weatherholtz, R., Reid, R., Becenti, J., Kvamme, S., Whitney, C. G., & Santosham, M. (2007) · The Journal of Infectious Diseases · doi:10.1086/521833 · Cited by 260
Simonsen, L., Taylor, R. J., Young-Xu, Y., Haber, M., May, L., & Klugman, K. P. (2011) · mBio · doi:10.1128/mbio.00309-10 · Cited by 256
Self-citationLewnard, J. A., Charani, E., Gleason, A., Hsu, L. Y., Khan, W. A., Karkey, A., Chandler, C. I. R., Mashe, T., Khan, E. A., Bulabula, A. N. H., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00862-6 · Cited by 220
Abdullahi, O., Nyiro, J., Lewa, P., Slack, M., & Scott, J. A. G. (2008) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31814da70c · Cited by 168
Bacterial pneumonia and pandemic influenza planning.
Gupta, R. K., George, R., & Nguyen-Van-Tam, J. S. (2008) · Emerging infectious diseases · doi:10.3201/eid1408.070751 · Cited by 132
Madhi, S. A., Adrian, P., Kuwanda, L., Cutland, C., Albrich, W. C., & Klugman, K. P. (2007) · The Journal of Infectious Diseases · doi:10.1086/522164 · Cited by 125
Self-citationMina, M. J., McCullers, J. A., & Klugman, K. P. (2014) · mBio · doi:10.1128/mbio.01040-13 · Cited by 91
Self-citationThe Impact and Burden of Neurological Sequelae Following Bacterial Meningitis: A Narrative Review
Schiess, N., Groce, N. E., & Dua, T. (2021) · Microorganisms · doi:10.3390/microorganisms9050900 · Cited by 85
Ibrahim, A. S., Spellberg, B. J., Avenissian, V., Fu, Y., Filler, S. G., & Edwards, J. E. (2005) · Infection and Immunity · doi:10.1128/iai.73.2.999-1005.2005 · Cited by 83
Metadata
- Authors
- Klugman, K. P., Madhi, S. A., Huebner, R. E., Kohberger, R., Mbelle, N., & Pierce, N.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-10-02
- Volume
- 349
- Issue
- 14
- Pages
- 1341-1348
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2075357156
- Cited by
- 1,009
- References
- 22
- FWCI
- 41.70
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.